Skip to main content
Log in

Hyperemesis Gravidarum: Risk of Recurrence in Subsequent Pregnancies

  • Pregnancy: Original Article
  • Published:
Reproductive Sciences Aims and scope Submit manuscript

Abstract

This study aimed to examine whether the recurrence risk of hyperemesis gravidarum (HG) is modified by the timing of diagnosis, the severity of illness, and interpregnancy interval. The Kaiser Permanente Southern California 1998–2020 longitudinally linked medical records were used to examine the recurrence risk of HG in the first two (n = 93,444) and first three (n = 17,492) successive pregnancies. The timing of diagnosis- and the severity of illness-specific recurrence risks were examined by estimating the adjusted relative risks (aRR). The risks of HG in the second pregnancy among patients with and without previous HG were 23.8% and 3.4%, respectively (aRR: 8.20; 95% confidence interval [CI]: 7.52, 8.94). The recurrence risk persisted regardless of the trimester at diagnosis and the gestational age of delivery in the first pregnancy. The recurrence risk was greater for patients with metabolic disturbances requiring in-hospital treatment (30.0%) than those managed on an outpatient basis (18.6%) in the first pregnancy (aRR: 10.84 95% CI: 9.66, 12.16). Although Asian/Pacific Islander (RR = 12.9) and White (RR = 8.9) patients had higher HG recurrence risk regardless of the gestational age at delivery in the first pregnancy, all patients had significant recurrence risk only if their first pregnancy was delivered after 32 weeks of gestation. African American patients had the highest recurrence rate (34.4%). HG recurrence risk was unaffected by interpregnancy interval and correlated with the number of previous pregnancies complicated by HG. There is an increased recurrence risk of HG in subsequent pregnancies that is influenced by race/ethnicity and gestational age at delivery. The number of pregnancies complicated by HG synergistically adds to the recurrence risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2015;9:Cd007575. https://doi.org/10.1002/14651858.CD007575.

  2. Jansen LAW, Koot MH, Van’tHooft J, Dean CR, Bossuyt PMM, Ganzevoort W, Gauw N, Van der Goes BY, Rodenburg J, Roseboom TJ, et al. The windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition. Eur J Obstet Gynecol Reprod Biol. 2021;266:15–22.

    Article  CAS  PubMed  Google Scholar 

  3. Gazmararian JA, Petersen R, Jamieson DJ, Schild L, Adams MM, Deshpande AD, Franks AL. Hospitalizations during pregnancy among managed care enrollees. Obstet Gynecol. 2002;100:94–100.

    PubMed  Google Scholar 

  4. Adams MM, Harlass FE, Sarno AP, Read JA, Rawlings JS. Antenatal hospitalization among enlisted servicewomen, 1987–1990. Obstet Gynecol. 1994;84:35–9.

    CAS  PubMed  Google Scholar 

  5. McCarthy FP, Khashan AS, North RA, Moss-Morris R, Baker PN, Dekker G, Poston L, Kenny LC, Consortium S. A prospective cohort study investigating associations between hyperemesis gravidarum and cognitive, behavioural and emotional well-being in pregnancy. PLoS ONE. 2011;6:e27678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fejzo MS, Poursharif B, Korst LM, Munch S, MacGibbon KW, Romero R, Goodwin TM. Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum. J Womens Health (Larchmt). 2009;18:1981–7.

    Article  PubMed  Google Scholar 

  7. Dean CR, Bruin CM, O’Hara ME, Roseboom TJ, Leeflang MM, Spijker R, Painter RC. The chance of recurrence of hyperemesis gravidarum: a systematic review. Eur J Obstet Gynecol Reprod Biol X. 2020;5:100105.

    Article  PubMed  Google Scholar 

  8. Nijsten K, Dean C, van der Minnen LM, Bais JMJ, Ris-Stalpers C, van Eekelen R, Bremer HA, van der Ham DP, Heidema WM, Huisjes A, et al. Recurrence, postponing pregnancy, and termination rates after hyperemesis gravidarum: follow up of the MOTHER study. Acta Obstet Gynecol Scand. 2021;100:1636–43.

    Article  PubMed  Google Scholar 

  9. Getahun D, Fassett MJ, Jacobsen SJ, Xiang AH, Takhar HS, Wing DA, Peltier MR. Autism spectrum disorders in children exposed in utero to hyperemesis gravidarum. Am J Perinatol. 2021;38:265–72.

    Article  PubMed  Google Scholar 

  10. Sanu O, Lamont RF. Hyperemesis gravidarum: pathogenesis and the use of antiemetic agents. Expert Opin Pharmacother. 2011;12:737–48.

    Article  PubMed  Google Scholar 

  11. Vikanes A, Skjaerven R, Grjibovski AM, Gunnes N, Vangen S, Magnus P. Recurrence of hyperemesis gravidarum across generations: population based cohort study. BMJ. 2010;340:c2050.

    PubMed  PubMed Central  Google Scholar 

  12. Fejzo MS, Sazonova OV, Sathirapongsasuti JF, Hallgrimsdottir IB, Vacic V, MacGibbon KW, Schoenberg FP, Mancuso N, Slamon DJ, Mullin PM. andMe Research T: Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun. 2018;9:1178.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Fejzo MS, Arzy D, Tian R, MacGibbon KW, Mullin PM. Evidence GDF15 plays a role in familial and recurrent hyperemesis gravidarum. Geburtshilfe Frauenheilkd. 2018;78:866–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fejzo MS, Fasching PA, Schneider MO, Schwitulla J, Beckmann MW, Schwenke E, MacGibbon KW, Mullin PM. Analysis of GDF15 and IGFBP7 in hyperemesis gravidarum support causality. Geburtshilfe Frauenheilkd. 2019;79:382–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2011;156:56–9.

    Article  PubMed  Google Scholar 

  16. Fell DB, Dodds L, Joseph KS, Allen VM, Butler B. Risk factors for hyperemesis gravidarum requiring hospital admission during pregnancy. Obstet Gynecol. 2006;107:277–84.

    Article  PubMed  Google Scholar 

  17. Vikanes A, Grjibovski AM, Vangen S, Gunnes N, Samuelsen SO, Magnus P. Maternal body composition, smoking, and hyperemesis gravidarum. Ann Epidemiol. 2010;20:592–8.

    Article  PubMed  Google Scholar 

  18. Fiaschi L, Nelson-Piercy C, Tata LJ. Hospital admission for hyperemesis gravidarum: a nationwide study of occurrence, reoccurrence and risk factors among 8.2 million pregnancies. Hum Reprod. 2016;31:1675–84.

    Article  CAS  PubMed  Google Scholar 

  19. Rashid M, Rashid MH, Malik F, Herath RP. Hyperemesis gravidarum and fetal gender: a retrospective study. J Obstet Gynaecol. 2012;32:475–8.

    Article  CAS  PubMed  Google Scholar 

  20. Mullin PM, Ching C, Schoenberg F, MacGibbon K, Romero R, Goodwin TM, Fejzo MS. Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum. J Matern Fetal Neonatal Med. 2012;25:632–6.

    Article  PubMed  Google Scholar 

  21. Fejzo MS, Macgibbon KW, Romero R, Goodwin TM, Mullin PM. Recurrence risk of hyperemesis gravidarum. J Midwifery Womens Health. 2011;56:132–6.

    Article  PubMed  Google Scholar 

  22. Korevaar TI, Steegers EA, de Rijke YB, Schalekamp-Timmermans S, Visser WE, Hofman A, Jaddoe VW, Tiemeier H, Visser TJ, Medici M, Peeters RP. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30:1057–66.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Derbent AU, Yanik FF, Simavli S, Atasoy L, Urun E, Kuscu UE, Turhan NO. First trimester maternal serum PAPP-A and free beta-HCG levels in hyperemesis gravidarum. Prenat Diagn. 2011;31:450–3.

    Article  CAS  PubMed  Google Scholar 

  24. Sandven I, Abdelnoor M, Nesheim BI, Melby KK. Helicobacter pylori infection and hyperemesis gravidarum: a systematic review and meta-analysis of case-control studies. Acta Obstet Gynecol Scand. 2009;88:1190–200.

    Article  PubMed  Google Scholar 

  25. Trogstad LI, Stoltenberg C, Magnus P, Skjaerven R, Irgens LM. Recurrence risk in hyperemesis gravidarum. Bjog. 2005;112:1641–5.

    Article  PubMed  Google Scholar 

  26. O’Hara ME. Experiences of hyperemesis gravidarum in a subsequent pregnancy. Midirs. 2017;27(3):309–18.

    Google Scholar 

  27. Koebnick C, Langer-Gould AM, Gould MK, Chao CR, Iyer RL, Smith N, Chen W, Jacobsen SJ. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012;16:37–41.

    Article  PubMed  PubMed Central  Google Scholar 

  28. ACOG Practice Bulletin No. 189: Nausea and vomiting of pregnancy. Obstet Gynecol. 2018;131:e15–30.

    Article  Google Scholar 

  29. Goodwin TM, Montoro M, Mestman JH, Pekary AE, Hershman JM. The role of chorionic gonadotropin in transient hyperthyroidism of hyperemesis gravidarum. J Clin Endocrinol Metab. 1992;75:1333–7.

    CAS  PubMed  Google Scholar 

  30. Getahun D, Rhoads GG, Fassett MJ, Chen W, Strauss JA, Demissie K, Jacobsen SJ: Accuracy of reporting maternal and infant perinatal service system coding and clinical utilization coding. J Med Stat Inform 2013;1:1–3. http://www.hoajonline.com/medicalstat/2053-7662/2051/2053. Accessed 15 Aug 2022

  31. Andrade SE, Scott PE, Davis RL, Li DK, Getahun D, Cheetham TC, Raebel MA, Toh S, Dublin S, Pawloski PA, et al. Validity of health plan and birth certificate data for pregnancy research. Pharmacoepidemiol Drug Saf. 2013;22:7–15.

    Article  PubMed  Google Scholar 

  32. Vikanes A, Grjibovski AM, Vangen S, Magnus P. Variations in prevalence of hyperemesis gravidarum by country of birth: a study of 900,074 pregnancies in Norway, 1967–2005. Scand J Public Health. 2008;36:135–42.

    Article  PubMed  Google Scholar 

  33. Depue RH, Bernstein L, Ross RK, Judd HL, Henderson BE. Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other maternal factors: a seroepidemiologic study. Am J Obstet Gynecol. 1987;156:1137–41.

    Article  CAS  PubMed  Google Scholar 

  34. Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1 Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. 2006;102:145–50.

    Article  CAS  PubMed  Google Scholar 

  35. McCarthy FP, Khashan AS, North RA, Moss-Morris R, Baker PN, Dekker G, Poston L, Kenny LC. A prospective cohort study investigating associations between hyperemesis gravidarum and cognitive, behavioural and emotional well-being in pregnancy. PLoS ONE. 2011;6:e27678.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Hromadnikova I, Kotlabova K, Ondrackova M, Pirkova P, Kestlerova A, Novotna V, Hympanova L, Krofta L. Expression profile of C19MC microRNAs in placental tissue in pregnancy-related complications. DNA Cell Biol. 2015;34:437–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Ms. Sole Cardoso and Ms. Chantal C. Avila for their technical support. Dr. Getahun and Ms. Chiu had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. The study team would like to thank the Kaiser Permanente member patients who contributed electronic health information to this study.

Funding

This study is supported by the Kaiser Permanente Direct Community Benefit Funds.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Darios Getahun.

Ethics declarations

Disclaimer

The opinions expressed are solely the authors’ responsibility and do not necessarily reflect the official views of the Kaiser Permanente Community Benefit Funds. The funding agency has no role in the design, conduct, and report of this study.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fassett, M.J., Peltier, M.R., Lopez, A.H. et al. Hyperemesis Gravidarum: Risk of Recurrence in Subsequent Pregnancies. Reprod. Sci. 30, 1198–1206 (2023). https://doi.org/10.1007/s43032-022-01078-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s43032-022-01078-8

Keywords

Navigation